Dr. Brenden Curti, MD

Claim this profile
Studies Squamous Cell Carcinoma
Studies Skin Cancer
1 reported clinical trial
1 drug studied

Area of expertise

1Squamous Cell Carcinoma
Brenden Curti, MD has run 1 trial for Squamous Cell Carcinoma. Some of their research focus areas include:
Stage III
Stage IV
2Skin Cancer
Brenden Curti, MD has run 1 trial for Skin Cancer. Some of their research focus areas include:
Stage III
Stage IV

More about Brenden Curti, MD

Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Brenden Curti, MD has experience with
  • MEDI0562

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brenden Curti, MD specialize in?
Brenden Curti, MD focuses on Squamous Cell Carcinoma and Skin Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage III patients, or patients who are Stage IV.
Is Brenden Curti, MD currently recruiting for clinical trials?
No, Brenden Curti, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Brenden Curti, MD has studied deeply?
Yes, Brenden Curti, MD has studied treatments such as MEDI0562.
What is the best way to schedule an appointment with Brenden Curti, MD?
Apply for one of the trials that Brenden Curti, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.